Thousand Oaks immunotherapy maker Atara Biotherapeutics announced plans to raise $175.5 million in a secondary public offering. The company filed with the Securities and Exchange Commission to conduct an underwritten public offering of 12.6 million shares of common stock at $11.32 per share. Another 2.9 million in pre-funded warrants are being offered to other investors,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
